ConvaTec Group PLC (LON:CTEC) Insider Karim Bitar Sells 436,692 Shares

ConvaTec Group PLC (LON:CTEC - Get Free Report) insider Karim Bitar sold 436,692 shares of the business's stock in a transaction on Monday, March 17th. The stock was sold at an average price of GBX 256 ($3.31), for a total value of £1,117,931.52 ($1,443,423.52).

Karim Bitar also recently made the following trade(s):

• On Friday, March 14th, Karim Bitar sold 132,253 shares of ConvaTec Group stock. The stock was sold at an average price of GBX 256 ($3.31), for a total value of £338,567.68 ($437,143.55).

ConvaTec Group Price Performance

CTEC traded down GBX 2 ($0.03) on Friday, reaching GBX 257 ($3.32). The stock had a trading volume of 11,241,307 shares, compared to its average volume of 20,111,834. ConvaTec Group PLC has a fifty-two week low of GBX 211.80 ($2.73) and a fifty-two week high of GBX 295.20 ($3.81). The firm has a 50-day moving average of GBX 248.35 and a 200-day moving average of GBX 234.96. The company has a current ratio of 2.26, a quick ratio of 0.96 and a debt-to-equity ratio of 85.32. The company has a market capitalization of £6.54 billion, a price-to-earnings ratio of 43.28, a price-to-earnings-growth ratio of 0.93 and a beta of 0.64.

ConvaTec Group Increases Dividend

The company also recently announced a dividend, which will be paid on Thursday, May 29th. Shareholders of record on Thursday, April 17th will be issued a $0.05 dividend. This represents a yield of 1.36%. The ex-dividend date of this dividend is Thursday, April 17th. This is a boost from ConvaTec Group's previous dividend of $0.02. ConvaTec Group's dividend payout ratio is presently 84.20%.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank reissued a "buy" rating and set a GBX 310 ($4.00) price target on shares of ConvaTec Group in a report on Wednesday, March 5th.

Remove Ads

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.